Description

ABLE C Competent Cells for toxic clones reduce copy number fourfold compared to the XL1-Blue strain. Reduces the copy number of ColE1-derived plasmids (such as pUC and pBluescript® plasmids) four-fold Decreases level of cloned protein product to increase cell viability Transformation efficiency of 5 x 10^6 – 2 x 10^7 transformants/µg Also available in an electroporation-competent version ABLE C Competent Cells for toxic clones enhance the probability of cloning DNA encoding toxic proteins. By reducing the copy number of ColE1-derived plasmids, the ABLE C strain decreases the levels of cloned gene products and enhances the probability of propagating a toxic clone. The ABLE C Competent Cells provide a viable alternative to commonly used cloning vectors with high copy numbers. Positive clones observed on initial screening of lambda libraries can be excised or re-cloned into any convenient vector and can be introduced into ABLE C strains. This product is only available to U.S. Domestic Customers. For research use only, not to be used in diagnostic procedures.